Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (271-280 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|March 1, 2014
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activityK P Callahan, M Minhajuddin, C Corbett, et al.
Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.
Leukemia|June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in miceA J Deshpande, A Rouhi, Y Lin, et al.
Leukemia|June 18, 2011
Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeatsM van der Burg, H Kreyenberg, A Willasch, et al.
Leukemia|July 27, 2011
The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cellsK A Monaghan, T Khong, C J Burns, et al.
Leukemia|July 27, 2011
Mobilization of stem and progenitor cells in cardiovascular diseasesW Wojakowski, U Landmesser, R Bachowski, et al.
Leukemia|August 17, 2011
Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remissionW-C Chou, K-Y Peng, W-C Lei, et al.
Leukemia|July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group studyS K Kumar, J H Lee, J J Lahuerta, et al.
Leukemia|July 30, 2011
RUNX1-ETO deregulates the proliferation and growth factor responsiveness of human hematopoietic progenitor cells downstream of the myeloid transcription factor, MYCT1K Liddiard, A K Burnett, R L Darley, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
Pageof 1,398

Showing results (271-280 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|March 1, 2014
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activityK P Callahan, M Minhajuddin, C Corbett, et al.
Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.
Leukemia|June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in miceA J Deshpande, A Rouhi, Y Lin, et al.
Leukemia|June 18, 2011
Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeatsM van der Burg, H Kreyenberg, A Willasch, et al.
Leukemia|July 27, 2011
The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cellsK A Monaghan, T Khong, C J Burns, et al.
Leukemia|July 27, 2011
Mobilization of stem and progenitor cells in cardiovascular diseasesW Wojakowski, U Landmesser, R Bachowski, et al.
Leukemia|August 17, 2011
Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remissionW-C Chou, K-Y Peng, W-C Lei, et al.
Leukemia|July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group studyS K Kumar, J H Lee, J J Lahuerta, et al.
Leukemia|July 30, 2011
RUNX1-ETO deregulates the proliferation and growth factor responsiveness of human hematopoietic progenitor cells downstream of the myeloid transcription factor, MYCT1K Liddiard, A K Burnett, R L Darley, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
Pageof 1,398